ReviewFrontiers in neuroscience2022

Ceftriaxone as a Novel Therapeutic Agent for Hyperglutamatergic States: Bridging the Gap Between Preclinical Results and Clinical Translation.

Osama A Abulseoud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.